Trial reportMedical science monitor : international medical journal of experimental and clinical research2025
Predictive Value of Anion Gap for Acute Kidney Injury Progression and Outcomes.
Trial report in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Anion gap (AG) is a cheap blood test, but the relationship between the AG at the onset of AKI and the progression and prognosis of AKI is unclear. This study explored the relationship between the AG at the onset of AKI and the progression and prognosis of AKI. MATERIAL AND METHODS We retrospectively analyzed data from a multicenter randomized study on an AKI early warning system. Univariate analysis, multivariate logistic regression, and curve fitting were used to assess the relationship between the AG at the onset of AKI and the AKI progression and prognosis of patients with AKI. RESULTS A total 5731 patients were included in our study. We found that AG at the onset of AKI was associated with 14-day AKI progression, 14-day dialysis, and 14-day mortality, and the adjusted ORs were 1.07 (1.04, 1.09), 1.09 (1.04, 1.15), and 1.10 (1.07, 1.14), respectively. Further curve fitting analysis found that there was a nonlinear correlation between the AG at the onset of AKI and 14-day AKI progression and 14-day mortality, and there was a linear correlation between the AG at the onset of AKI and 14-day dialysis. When the AG was >10 mmol/L, 14-day AKI progression and 14-day mortality were significantly increased. CONCLUSIONS An increase of AG at the onset of AKI was associated with an increased risk of 14-day AKI progression, 14-day dialysis, and 14-day mortality. Especially when the AG exceeded 10 mmol/L, the 14-day AKI progression and 14-day mortality were significantly increased, and the AG showed a linear correlation with 14-day dialysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.